Australian researchers warn GLP-1 weight-loss drugs may raise risk of scurvy, wounds ‘failing to heal’ properly

Researchers in Australia are warning that GLP-1 weight-loss drugs may increase the risk of developing scurvy, a rare disease caused by vitamin C deficiency. Historically known as a “pirate disease” because sailors often lacked fresh produce during long sea voyages, scurvy can become severe if not treated, according to a report by Fox News. According…

Read More

Novo Nordisk stock jumps over 8% after rival Hims & Hers withdraws knockoff weight-loss drug amid FDA scrutiny

Denmark-based pharmaceutical giant, Novo Nordisk, stock surged more than 8% during the intraday trading session on Monday, 9 February 2026, after rival healthcare firm Hims & Hers withdrew its knockoff weight-loss drug from the market amid US Food and Drug Administration (FDA) scrutiny. Novo Nordisk stock jumped 8.6% to 321 Danish Krone (kr) during the…

Read More